1-7 of 7
Ramaditya Srinivasmurthy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incidence of bleeding and hypertension in patients with hematologic malignancies treated with next-generation Bruton tyrosine kinase (BTK) inhibitors: A meta-analysis of randomized controlled trials

Free
Jason Ta, Abbas Hussain, Daniel Jones, Ramaditya Srinivasmurthy, Rishi Nanda, Riccesha Hattin, Arbab Khalid, Sajal Ahmad, Sharif Afifi, Zin Win, Tin Tun, Manraj Dhillon, Kyaw Zin Thein, Thura Htut
Journal: Blood
Blood (2025) 146 (Supplement 1): 2739.
https://doi.org/10.1182/blood-2025-2739
Published: 2025
Journal Articles

Incidence of cardiac events associated with next-generation bruton tyrosine kinase (BTK) inhibitors compared to control in hematologic malignancies: A meta-analysis of randomized trials

Free
Ramaditya Srinivasmurthy, Abbas Hussain, Rishi Nanda, Daniel Jones, Jason Ta, Riccesha Hattin, Arbab Khalid, Sajal Ahmad, Sharif Afifi, Zin Win, Tin Tun, Manraj Dhillon, Kyaw Zin Thein, Thura Htut
Journal: Blood
Blood (2025) 146 (Supplement 1): 8067.
https://doi.org/10.1182/blood-2025-8067
Published: 2025
Journal Articles

Incidence of cardiac toxicities in patients with hematologic malignancies treated with zanubrutinib compared to control, including BTK inhibitor (Ibrutinib): A meta-analysis of randomized controlled trials

Free
Abbas Hussain, Daniel Jones, Jason Ta, Ramaditya Srinivasmurthy, Rishi Nanda, Riccesha Hattin, Laceyahna Winland, Preny Karamian, Yousef Joseph, Khadija Mohib, Zin Win, Tin Tun, Manraj Dhillion, Kyaw Zin Thein, Thura Htut
Journal: Blood
Blood (2025) 146 (Supplement 1): 4554.
https://doi.org/10.1182/blood-2025-4554
Published: 2025
Journal Articles

Incidence of second primary malignancies in patients with hematologic malignancies treated with next-generation bruton tyrosine kinase (BTK) inhibitors: A meta-analysis of randomized controlled trials

Free
Rishi Nanda, Daniel Jones, Ramaditya Srinivasmurthy, Jason Ta, Abbas Hussain, Riccesha Hattin, Laceyahna Winland, Preny Karamian, Yousef Joseph, Khadija Mohib, Yin Mon Myat, Tin Tun, Manraj Dhillon, Kyaw Zin Thein, Thura Htut
Journal: Blood
Blood (2025) 146 (Supplement 1): 4552.
https://doi.org/10.1182/blood-2025-4552
Published: 2025
Journal Articles

Efficacy of Isatuximab Combination Regimens in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials

Free
Hazem Aboaid, Ramaditya Srinivasmurthy, Daniel Thomas Jones, Kevin Nguyen, Rishi Kumar Nanda, Kyaw Zin Thein, Thura Win Htut
Journal: Blood
Blood (2024) 144 (Supplement 1): 7036.
https://doi.org/10.1182/blood-2024-209018
Published: 2024
Journal Articles

Updated Meta-Analysis of Phase III Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Second Primary Malignancies (SPMs) in Patients with Multiple Myeloma (MM) Treated with Isatuximab

Free
Hazem Aboaid, Kevin Nguyen, Daniel Thomas Jones, Ramaditya Srinivasmurthy, Rishi Kumar Nanda, Kyaw Zin Thein, Thura Win Htut
Journal: Blood
Blood (2024) 144 (Supplement 1): 7866.
https://doi.org/10.1182/blood-2024-211236
Published: 2024
Journal Articles

Updated Meta-Analysis of Phase III Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Pneumonia, Upper Respiratory Tract Infections (URTIs) and Venous Thromboembolism (VTE) in Patients with Multiple Myeloma Treated with Isatuximab

Free
Daniel Thomas Jones, Hazem Aboaid, Ramaditya Srinivasmurthy, Kevin Nguyen, Rishi Kumar Nanda, Kyaw Zin Thein, Thura Win Htut
Journal: Blood
Blood (2024) 144 (Supplement 1): 2390.
https://doi.org/10.1182/blood-2024-211295
Published: 2024